The anti-synthetase syndrome is represented by the association of in-flammatory myopathy (polymyositis/dermatomyositis), interstitial pneu-monitis, Raynaud’s syndrome, inflammatory polyarthritis, and characteristic skin abnormalities. We found also a clinical aspects of Mechanic’s hand with high level of anti-synthetases. We report the case of a 66-year-old patient with polyar- thralgias of large and small inflammatory joints, myositis, Raynaud’s phenomenon, and cutaneous involvement of the hands and feet, with fissure hyperkeratosis feet and an appearance of mechanic’s hands. The patient had an inflammatory syndrome, elevated muscle enzymes, positivity of anti-Jo1 antibodies, PID at chest CT and the presence of inflammatory mononuclear cell infiltrates at muscle biopsy. The evolution under immunosuppressive treatment combining corticosteroids and methotrexate was marked by an oedemato-ascitic decompensation of a post-HVB cirrhosis unknown.
Cite this paper
Omari, H. , Bellabah, A. , Tahiri, M. , Haddad, F. , Hliwa, W. and Badre, W. (2019). New Case of Anti-Synthetase Syndrome Associated with Cirrhosis Post HVB. Open Access Library Journal, 6, e5753. doi: http://dx.doi.org/10.4236/oalib.1105753.
Connors, G.R., Christopher-Stine, L., Oddis, C.V. and Danoff, S.K. (2010) Interstitial Lung Disease Associated with the Idiopathic Inflammatory Myopathies: What Progress Has Been Made in the Past 35 Years? Chest, 138, 1464-1474. https://doi.org/10.1378/chest.10-0180
Katzap, E., Barilla-LaBarca, M.L. and Marder, G. (2011) Antisynthetase Syndrome. Current Rheumatology Reports, 13, 175-181. https://doi.org/10.1007/s11926-011-0176-8
Hirakata, M., Suwa, A., Nagai, S., Kron, M.A., Trieu, E.P., Mimori, T., et al. (1999) Anti-KS: Identification of Autoantibodies to Asparaginyl-Transfer RNA Synthetase Associated with Interstitial Lung Disease. The Journal of Immunology, 162, 2315-2320.
Fischer, A., Swigris, J.J., du Bois, R.M., Lynch, D.A., Downey, G.P., Cosgrove, G.P., et al. (2009) Anti-Synthetase Syndrome in ANA and Anti-Jo-1 Negative Patients Presenting with Idiopathic Interstitial Pneumonia. Respiratory Medicine, 103, 1719-1724. https://doi.org/10.1016/j.rmed.2009.05.001
Targoff, I.N., Trieu, E.P. and Miller, F.W. (1993) Reaction of Anti-OJ Autoantibodies with Components of the Multienzyme Complex of Aminoacyl-tRNA Synthetases in Addition to Isoleucyl-tRNA Synthetase. Journal of Clinical Investigation, 91, 2556-2564. https://doi.org/10.1172/JCI116493
Chatte, G. and Boyer, J. (1992) Pneumo-pathie interstitielle fibrosante et dermatomyosite, Histologie pulmonaire et pronostic. Revue des Maladies Respiratoires, 9, 634-635.
Nine, H.M. and Nagai, S. (2000) Interstitial Lung Disease in Polymyositis and Dermatomyositis. Current Opinion in Rheumatology, 12, 501-508. https://doi.org/10.1097/00002281-200011000-00005
Costabel, U. and King, T.E. (2001) International Consensus Statement on Idiopathic Pulmonary Fibrosis. European Respiratory Journal, 17, 163-167. https://doi.org/10.1183/09031936.01.17201630
al-Janadi, M., Smith, C.D. and Karsh, J. (1989) Cyclophosphamide Treatment of Interstitial Pulmonary Fibrosis in Polymyositis/Dermatomyositis. The Journal of Rheumatology, 16, 1592-1596.
Qushmaq, K.A., Chalmers, A. and Esdaile, J.M. (2000) Cyclosporin A in the Treatment of Refractory Adult Polymyositis/Dermatomyositis: Population Based Experience in 6 Patients and Literature Review. The Journal of Rheumatology, 27, 2855-2859.
Tellus, M.M. and Buchanan, R.R. (1995) Effective Treatment of Anti Jo-1 Antibodypositive Polymyositis with Cyclosporine. British Journal of Rheumatology, 34, 1187-1188. https://doi.org/10.1093/rheumatology/34.12.1187
Joffe, M.M., Love, L.A., Leff, R.L., Fraser, D.D., Targoff, I.N., Hicks, J.E., et al. (1993) Drug Therapy of the Idiopathic Inflammatory Myopathies: Predictors of Response to Prednisone, Azathioprine and Methotrexate and a Comparison of Their Efficacy. The American Journal of Medicine, 94, 379-387. https://doi.org/10.1016/0002-9343(93)90148-I
Cherin, P., Pelletier, S., Teixeira, A., Laforet, P., Genereau, T., Simon, A., et al. (2002) Results and Long-Term Followup of Intravenous Immunoglobulin Infusions in Chronic, Refractory Polymyositis: An Open Study with Thirtyfive Adult Patients. Arthritis & Rheumatology, 46, 467-474. https://doi.org/10.1002/art.10053
Cherin, P., Herson, S., Wechsler, B., Piette, J.C., Bletry, O., Coutellier, A., et al. (1991) Efficacy of Intravenous Gammaglobulin Therapy in Chronic Refractory Polymyositis and Dermatomyositis: An Open Study with 20 Adult Patients. The American Journal of Medicine, 91, 162-168. https://doi.org/10.1016/0002-9343(91)90009-M
Cherin, P. and Herson, S. (1999) Les immunoglobulines intraveineuses dans les polymyosites et les dermatomyosites. La Revue de Médecine Interne, 20, 436s-439s. https://doi.org/10.1016/S0248-8663(00)88675-0
Lim, H.-W. and Silver, J. (2017) Not So Cryptogenic: An Unusual Case of Antisynthetase Syndrome and Cirrhosis. Hospital Medicine, Las Vegas, 1-4 May 2017, 4.
Agha, B., Rasheed, M., Kenyon, L. and Jimenez, S.A. (2002) Hepatitis C Virus Infection, Inflammatory Myopathy, and Pulmonary Fibrosis: Are They Related? Journal of Clinical Rheumatology, 8, 44-49. https://doi.org/10.1097/00124743-200202000-00010
Casta？eda-Pomeda, M., Prieto-González, S. and Grau, J.M. (2011) Antisynthetase Syndrome and Malignancy: Our Experience. Journal of Clinical Rheumatology, 17, 458. https://doi.org/10.1097/RHU.0b013e31823b1878
Thanapirom, K., Aniwan, S. and Treeprasertsuk, S. (2014) Polymyositis Associated with Hepatitis B Virus Cirrhosis and Advanced Hepatocellular Carcinoma. ACG Case Reports Journal, 1, 167-169. https://doi.org/10.14309/crj.2014.39
Nojima, T., Hirakata, M., Sato, S., Fujii, T., Suwa, A., Mimori, T. and Ikeda, Y. (2000) A Case of Polymyositis Associated with Hepatitis B Infection. Clinical and Experimental Rheumatology, 18, 86-88.
Droz, N., Gilardin, L., Cacoub, P., et al. (2013) Kinetic Profiles and Man-agement of Hepatitis B Virus Reactivation in Patients with Immune-Mediated Inflam-matory Diseases. Arthritis Care & Research (Hoboken), 65, 1504-1514. https://doi.org/10.1002/acr.21990
Ito, S., Nakazono, K., Murasawa, A., et al. (2001) Development of Fulminant Hepatitis B (Precore Variant Mutant Type) after the Discontinuation of Low-Dose Methotrexate Therapy in a Rheumatoid Arthritis Patient. Arthritis & Rheumatology, 44, 339-342. https://doi.org/10.1002/1529-0131(200102)44:2<339:: AID-ANR51>3.0.CO;2-Q
